Assembly Biosciences Future Growth
Future criteria checks 0/6
Assembly Biosciences's revenue and earnings are forecast to decline at 45.3% and 22.8% per annum respectively while EPS is expected to decline by 17% per annum.
Key information
-22.8%
Earnings growth rate
-17.0%
EPS growth rate
Biotechs earnings growth | 30.4% |
Revenue growth rate | -45.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 09 Aug 2024 |
Recent future growth updates
Recent updates
Here's Why Assembly Biosciences (NASDAQ:ASMB) Must Use Its Cash Wisely
Aug 17Will Assembly Biosciences (NASDAQ:ASMB) Spend Its Cash Wisely?
Feb 27We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate
Nov 09Jason Okazaki to succeed John McHutchison as Assembly Biosciences CEO at year-end
Oct 05Assembly Biosciences to discontinue development of inhibitor vebicorvir, cut workforce
Jul 20We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate
Jun 08We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate
Jan 11We're Keeping An Eye On Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate
Sep 03Assembly Biosciences announces resignation of CFO
Jun 02Time To Worry? Analysts Just Downgraded Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Outlook
Mar 24Assembly Biosciences' (NASDAQ:ASMB) Shareholders Are Down 86% On Their Shares
Feb 05We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely
Dec 14Assembly Bio inks deal with Door Pharmaceuticals to develop HBV core protein modulators
Nov 16Assembly Biosciences EPS beats by $0.69, beats on revenue
Nov 05Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 7 | -86 | N/A | N/A | 1 |
12/31/2025 | 41 | -44 | N/A | N/A | 1 |
12/31/2024 | 32 | -45 | N/A | N/A | 1 |
6/30/2024 | 21 | -46 | 24 | 24 | N/A |
3/31/2024 | 13 | -51 | 28 | 28 | N/A |
12/31/2023 | 7 | -61 | 22 | 23 | N/A |
9/30/2023 | N/A | -73 | -70 | -70 | N/A |
6/30/2023 | N/A | -81 | -76 | -76 | N/A |
3/31/2023 | N/A | -89 | -80 | -80 | N/A |
12/31/2022 | N/A | -93 | -85 | -84 | N/A |
9/30/2022 | N/A | -131 | -85 | -85 | N/A |
6/30/2022 | 6 | -127 | -84 | -84 | N/A |
3/31/2022 | 6 | -126 | -88 | -88 | N/A |
12/31/2021 | 6 | -130 | -96 | -93 | N/A |
9/30/2021 | 7 | -109 | -104 | -99 | N/A |
6/30/2021 | 36 | -94 | -75 | -70 | N/A |
3/31/2021 | 75 | -63 | -76 | -71 | N/A |
12/31/2020 | 79 | -62 | -65 | -63 | N/A |
9/30/2020 | 83 | -50 | -59 | -58 | N/A |
6/30/2020 | 52 | -71 | -88 | -87 | N/A |
3/31/2020 | 16 | -97 | -85 | -85 | N/A |
12/31/2019 | 16 | -98 | -86 | -84 | N/A |
9/30/2019 | 15 | -97 | -82 | -80 | N/A |
6/30/2019 | 15 | -93 | -80 | -78 | N/A |
3/31/2019 | 15 | -102 | -75 | -73 | N/A |
12/31/2018 | 15 | -91 | -65 | -65 | N/A |
9/30/2018 | 14 | -68 | -58 | -58 | N/A |
6/30/2018 | 13 | -58 | -53 | -52 | N/A |
3/31/2018 | 12 | -45 | N/A | -49 | N/A |
12/31/2017 | 9 | -43 | N/A | 2 | N/A |
9/30/2017 | 6 | -51 | N/A | 1 | N/A |
6/30/2017 | 3 | -51 | N/A | 4 | N/A |
3/31/2017 | 1 | -47 | N/A | 9 | N/A |
12/31/2016 | N/A | -44 | N/A | -35 | N/A |
9/30/2016 | N/A | -40 | N/A | -29 | N/A |
6/30/2016 | N/A | -36 | N/A | -27 | N/A |
3/31/2016 | N/A | -32 | N/A | -24 | N/A |
12/31/2015 | N/A | -28 | N/A | -19 | N/A |
9/30/2015 | N/A | -27 | N/A | -17 | N/A |
6/30/2015 | N/A | -31 | N/A | -16 | N/A |
3/31/2015 | N/A | -27 | N/A | -13 | N/A |
12/31/2014 | N/A | -24 | N/A | -15 | N/A |
9/30/2014 | N/A | -24 | N/A | -17 | N/A |
6/30/2014 | N/A | -17 | N/A | -18 | N/A |
3/31/2014 | N/A | -20 | N/A | -19 | N/A |
12/31/2013 | N/A | -19 | N/A | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ASMB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ASMB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ASMB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ASMB's revenue is expected to decline over the next 3 years (-45.3% per year).
High Growth Revenue: ASMB's revenue is forecast to decline over the next 3 years (-45.3% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ASMB's Return on Equity is forecast to be high in 3 years time